US Patent Issued to CHINA PHARMACEUTICAL UNIVERSITY on May 27 for "Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,944, issued on May 27, was assigned to CHINA PHARMACEUTICAL UNIVERSITY (Nanjing, China).

"Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof" was invented by Haopeng Sun (Nanjing, China), Hongyu Yang (Nanjing, China), Tingkai Chen (Nanjing, China), Yao Chen (Nanjing, China), Feng Feng (Nanjing, China) and Chenxi Du (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a selective butyrylcholinesterase inhibitor having a general formula (I) or a pharmaceutically acceptable salt thereof, a preparation method and use thereof. The treatment ef...